Théa Launches Canadian Affiliate
Friday, January 13 2023 | 14 h 22 min | News
The successful completion of the five-year joint venture between two family-owned specialty eye care companies, Laboratoires Théa (“Théa”) based in France, and Canada’s Labtician Ophthalmics, has given rise to the newly minted Théa Pharma Inc (Théa Pharma Canada),with headquarters in Toronto, Ontario.
Both organizations benefited from their collaboration over the last 5 years and are now well positioned to pursue their distinct specialties. With the goal of becoming Canada’s leading provider of preservative-free eye care solutions, Théa Pharma Canada will devote 100% of its attention to eye care, and to the professionals who manage the eye health of Canadians across the country.
Théa Pharma Canada has plans to accelerate its growth and presence in Canada by leveraging the culture and values of its family-owned and run parent company, Théa, Europe’s leading and pioneering eye health brand founded in 1994 by Henri Chibret.
As an affiliate of a highly successful global entity, Théa Pharma Canada will leverage global reinvestment in R&D to introduce new and novel preservative-free treatments to the Canadian market, as well as provide access for Canadian eye care professionals to value-added education, training and other programs led by world experts in eye care.
The transaction, which became effective on January 1, 2023, is significant for the Company on many levels. “Although our name is new, what will not change is our long-term commitment to Canadian ophthalmologists, optometrists, and their patients,” said Fiona McCloskey, General Manager, Théa Pharma Canada. “Canadian eye care professionals have come to rely on us for our cutting-edge
preservative-free treatments, but also see us as a valued partner in finding solutions to a wide range of ocular conditions including Dry Eye, Lid Margin Disease, Glaucoma, Allergy, and more.”
Click HERE for the full press release.
